A common polymorphism in the cannabinoid receptor 1 (CNR1) gene is associated with antipsychotic-induced weight gain in Schizophrenia
about
Alterations to melanocortinergic, GABAergic and cannabinoid neurotransmission associated with olanzapine-induced weight gainManagement of antipsychotic-related weight gainGenetics of Common Antipsychotic-Induced Adverse EffectsSignificant weight loss following clozapine use, how is it possible? A case report and review of published cases and literature relevant to the subjectTreatment-resistant schizophrenia: current insights on the pharmacogenomics of antipsychoticsAssociation between common variants near the melanocortin 4 receptor gene and severe antipsychotic drug-induced weight gainAntipsychotic drugs and obesity.Association of genetic variation in cannabinoid mechanisms and gastric motor functions and satiation in overweight and obesity.Contributions of endocannabinoid signaling to psychiatric disorders in humans: genetic and biochemical evidence.The role of the CNR1 gene in schizophrenia: a systematic review including unpublished data.Cannabinoid receptor 1 gene and irritable bowel syndrome: phenotype and quantitative traitsModeration of antipsychotic-induced weight gain by energy balance gene variants in the RUPP autism network risperidone studies.Antipsychotic drugs opposite to metabolic risk: neurotransmitters, neurohormonal and pharmacogenetic mechanisms underlying with weight gain and metabolic syndromeRandomized pharmacodynamic and pharmacogenetic trial of dronabinol effects on colon transit in irritable bowel syndrome-diarrhea.Effects of the cannabinoid-1 receptor antagonist/inverse agonist rimonabant on satiety signaling in overweight people with schizophrenia: a randomized, double-blind, pilot study.Pharmacogenetic testing to predict antipsychotic-induced weight gain: a systematic review.Pharmacogenetics of antipsychotic-induced weight gain: review and clinical implications.Pharmacogenetics of response to antipsychotics in patients with schizophrenia.Toward understanding genetic risk for differential antipsychotic response in individuals with schizophrenia.Atypical antipsychotic-induced weight gain: insights into mechanisms of action.Pharmacogenetic Aspects of Antipsychotic Drug-induced Weight Gain - A Critical Review.Pharmacogenetics in schizophrenia: a review of clozapine studies.Individualizing clozapine and risperidone treatment for schizophrenia patients.Antipsychotic induced weight gain: genetics, epigenetics, and biomarkers reviewed.Pharmacogenetic Associations of Antipsychotic Drug-Related Weight Gain: A Systematic Review and Meta-analysis.Endocannabinoids in the gastrointestinal tract.Investigation of TSPO variants in schizophrenia and antipsychotic treatment outcomes.Dopaminergic system genes in childhood aggression: possible role for DRD2.Pharmacogenetics of antipsychotic treatment response and side effects.Association study of cannabinoid receptor 1 (CNR1) gene in tardive dyskinesia.Genetic association study between antipsychotic-induced weight gain and the melanocortin-4 receptor gene.Genetic variation in the GCG and in the GLP1R genes and antipsychotic-induced weight gain.Antipsychotic-induced weight gain: can the energy balance gene variants help us tip the scales?Investigation of melanocortin system gene variants in antipsychotic-induced weight gain.Association Study of Serotonin 3 Receptor Subunit Gene Variants in Antipsychotic-Induced Weight Gain.Impact of histamine receptors H1 and H3 polymorphisms on antipsychotic-induced weight gain.A pharmacogenomic study revealed an association between SLC6A4 and risperidone-induced weight gain in Chinese Han population.Association of orexin receptor polymorphisms with antipsychotic-induced weight gain.Cannabinoid type 1 receptor gene polymorphisms are not associated with olanzapine-induced weight gain.Polymorphisms of the HTR2C gene and antipsychotic-induced weight gain: an update and meta-analysis.
P2860
Q21561008-2010D284-518E-43E9-8101-91CE4F01451EQ24610124-B0BA0858-2B00-4DC5-9940-F2E75058B4F1Q28072893-0D35FB2D-D147-4989-A240-38D70206224CQ28073082-17A83354-73A7-418F-B632-5538380D2E84Q28079065-C46071AA-1F35-454A-8BBB-C5AE2057A6C4Q28266158-38474E13-F011-4EFA-B442-6B6FE33C216DQ34648940-E3F1B64D-8751-434C-91BF-EC620EFC8406Q35053292-07966BC4-F2C8-4B48-AFB4-C627886DA1D9Q35784024-13AC4D2B-293D-4670-A343-F352A790E687Q36252902-CB2AA5F7-DDF9-4203-8749-3E1C6D1E7A39Q36699687-F0BB3045-1586-4BEC-A044-8EA229B9D316Q36956632-7C37D9D0-92D6-415F-8C22-11AE8B247BF0Q37043479-FC38823B-39FA-4412-BD95-E1AD00021A5EQ37178858-8A653712-9496-4912-AB8C-FF6EC3A4A05FQ37331672-03E37A49-4F0F-4CE3-B996-06F55360FD92Q37917782-F3047632-D6BC-4BBF-9DF5-03057ECC260FQ37926893-13070E66-BBDC-42E4-8325-ED8D09304F7FQ37952823-1E2E3FE7-411F-4658-B866-DC6522E5BDCEQ37960512-5C5C11F9-F8A4-49C3-8F56-D4D0AF8F5656Q37963571-AC8C4033-3F43-4A3E-9AA1-EEE3B0091A0DQ38083647-14EE6625-AFFF-4BA1-9F6C-8BFFEC6CAB95Q38154175-E4A7DD11-1747-4C66-8045-444FDCDB29AEQ38170458-75B8A849-0FAF-43A1-961C-CD2954D920ACQ38241344-BF6D71C3-7EAB-4565-BB24-2D8D5C582991Q38842714-608E1213-3754-432B-B7E3-6ED2B00264FEQ38931168-C73A887D-F7E6-4172-8414-5A0BF345424BQ39064271-CFB974EF-9A75-4888-B74F-724461E5197AQ39792385-D8050DD1-0949-4E92-9402-685FA37049D4Q40663726-30894E9A-33B5-4601-AFE0-2D0ADDAE1EE1Q45185178-5523A1DA-03C0-42AC-9AA9-BD60F034FFFAQ45817465-07DBBF65-65C7-4477-8403-F1AE0FCADB3EQ47178961-74331632-B7BA-4996-90CB-F139AD896DDDQ47178969-E0ECE93F-6FBD-4557-884B-060746428B9CQ47182191-20BB6EBE-E20A-4F1E-93A3-79F892045885Q47211764-F6298E0B-4CF0-4058-877B-C296092F0EE6Q47257590-5CEEA5E3-9816-4C06-BB24-562BAD793831Q47348196-6F785D17-94CC-4354-8A97-FC3AFE43CB64Q47355703-953F73CD-07BA-4BE3-AADE-1A726EB4336EQ47370318-C6963678-9E96-4B30-9E05-A54145D2CC20Q47402954-27467E41-5B34-4EC9-8C35-62F9EAAA006F
P2860
A common polymorphism in the cannabinoid receptor 1 (CNR1) gene is associated with antipsychotic-induced weight gain in Schizophrenia
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
A common polymorphism in the c ...... d weight gain in Schizophrenia
@ast
A common polymorphism in the c ...... d weight gain in Schizophrenia
@en
A common polymorphism in the cannabinoid receptor 1
@nl
type
label
A common polymorphism in the c ...... d weight gain in Schizophrenia
@ast
A common polymorphism in the c ...... d weight gain in Schizophrenia
@en
A common polymorphism in the cannabinoid receptor 1
@nl
prefLabel
A common polymorphism in the c ...... d weight gain in Schizophrenia
@ast
A common polymorphism in the c ...... d weight gain in Schizophrenia
@en
A common polymorphism in the cannabinoid receptor 1
@nl
P2093
P2860
P921
P356
P1476
A common polymorphism in the c ...... d weight gain in Schizophrenia
@en
P2093
Annika Lisker
Arun K Tiwari
Clement C Zai
Daniel J Müller
Deepika Singh
Herbert Y Meltzer
James L Kennedy
Olga Likhodi
P2860
P2888
P304
P356
10.1038/NPP.2009.235
P407
P577
2010-01-27T00:00:00Z
P5875
P6179
1024999485